Ten valent vaccine prevents most invasive pneumococcal disease

Lancet2012; doi:10.1016/S0140-6736(12)61854-6

GlaxoSmithKline have confirmed that their 10 valent pneumococcal vaccine prevents invasive disease in vaccinated infants. The vaccine was licensed in 2009, on the basis that it generated a good immune response. A new trial from Finland shows that it also prevents 92-100% of …